Grüneberg and Myers - Intellectual Property Law
webbanner6.png

kg

Dr. Kirsten Grüneberg

 

DR. KIRSTEN GRÜNEBERG

Partner

Kirsten_sm.jpg

kg@gandmpatent.com
+1 (571) 458-7783

Dr. Kirsten A. Grüneberg represents many of the world’s largest chemical, biotech, and pharmaceutical companies, including US Fortune 50 and Global Fortune 200 companies.

She has been named repeatedly by Intellectual Asset Management (IAM) as one of the nation’s top patent practitioners. IAM reported that “She has a deep reservoir of experience representing European and Japanese pharmaceutical and biotechnology companies – she understands their needs and how to contextualise them in US patent law on the way to creating compelling value propositions.”

She has successfully defended high value pharma patents in post-grant proceedings, helping to secure business deals worth several hundreds of millions of dollars.  Dr. Grüneberg also has significant experience with IP issues in connection with mergers and acquisitions in the U.S., Germany, Switzerland, Japan and China.

IAM 1000 recommended individual 2019.jpg

Dr. Grüneberg is active in the areas of opinions and counseling, post-grant proceedings including inter partes review and reexaminations, intellectual property portfolio management and development, chemical as well as pharmaceutical/medical devices patent prosecution. She is a native German speaker and regularly visits clients in Europe and Asia to update them about the latest developments in U.S. patent law and to work closely with them on selected high-profile projects.

Dr. Grüneberg is a contributor to the treatise entitled Post-Grant Proceedings Before the Patent Trial and Appeal Board, published by Practicing Law Institute. The treatise guides readers through the process of initiating a post-grant proceeding, taking discovery, seeking sanctions, proposing and opposing claim amendments, effectively advocating at the oral hearing, appealing to the Federal Circuit, and handling a wide array of issues involving co-pending district court litigation.

After receiving her Ph.D. in organic chemistry, magna cum laude, from the Technische Universität Berlin in Germany, Dr. Grüneberg was awarded a Lynen-Fellowship from the Alexander von Humboldt Foundation in Germany. This fellowship was to perform research during a three-year period at the Center for Bio/Molecular Science and Engineering of the U.S. Naval Research Laboratory. She also worked as a senior scientist at Geo-Centers, Inc./U.S. Naval Research Laboratory and as a research scientist at the Max-Planck-Institute of Colloids and Interfaces in Berlin. Dr. Grüneberg received her Masters of Science in organic chemistry, summa cum laude, and her Bachelors of Science in chemistry/chemical engineering, magna cum laude, from the E.-M.-Arndt-University in Germany.

Dr. Grüneberg has published more than 20 scientific papers in the areas of liquid crystals, display technology, organic thin films, polymers, surfactants, and antimicrobial materials. She has been an invited speaker regarding her research at international conferences in the U.S., Japan, Germany, Italy, Switzerland and South Korea, and is an inventor on several U.S. and foreign patents.